Page last updated: 2024-11-13

tetronothiodin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetronothiodin: from Streptomyces sp. NR0489; structure given in first source; cholecystokinin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54695534
CHEMBL ID3576924
MeSH IDM0198846

Synonyms (9)

Synonym
139643-79-1
3h,21h-19a,22-metheno-1h-thieno(3,4-e)(1)benzoxacycloeicosin-3-acetic acid, 3a,4,5,8,9,10,15,15a,18,19,23,23a-dodecahydro-9,24-dihydroxy-4,17,18-trimethyl-alpha,21,23-trioxo-
3a,4,5,8,9,10,15,15a,18,19,23,23a-dodecahydro-9,24-dihydroxy-4,17,18-trimethyl-alpha,21,23-trioxo-3h,21h-19a,22-metheno-1h-thieno(3,4-e)(1)benzoxacycloeicosin-3-acetic acid
gtpl910
2-[(8z,10e,15e)-13,26-dihydroxy-3,4,18-trimethyl-24,28-dioxo-27-oxa-21-thiatetracyclo[23.2.1.0^{1,6}.0^{19,23}]octacosa-4,8,10,15,25-pentaen-20-yl]-2-oxoacetic acid
tetronothiodin
bdbm50088529
chembl3576924 ,
Q27088970

Research Excerpts

Overview

Tetronothiodin (1) is a potent and selective cholecystokinin type B (CCK-B) receptor antagonist produced by Streptomyces sp.

ExcerptReferenceRelevance
"Tetronothiodin (1) is a potent and selective cholecystokinin type B (CCK-B) receptor antagonist produced by Streptomyces sp. "( Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation.
Itezono, Y; Kuwahara, T; Nakayama, N; Ohtsuka, T; Seto, H; Shimma, N; Yokose, K, 1993
)
3.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1346883Human CCK2 receptor (Cholecystokinin receptors)1993Neuroscience letters, Aug-06, Volume: 158, Issue:1
Species specificity of pharmacological characteristics of CCK-B receptors.
AID1225254Inhibition of CCK-B receptor in rat cerebral cortex2015Journal of natural products, Mar-27, Volume: 78, Issue:3
Spirotetronate polyketides as leads in drug discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]